Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KD-370 Phase III Clinical Study

Trial Profile

KD-370 Phase III Clinical Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2018

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; DTP poliovirus vaccine; Hib vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors KM Biologics
  • Most Recent Events

    • 04 Oct 2018 Status changed from recruiting to active, no longer recruiting.
    • 31 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top